Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - Chest, 2008 - Elsevier
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …

[PDF][PDF] Pharmacology and Management of the Vitamin K Antagonists

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - CHEST, 2008 - mrotte.com
Among the key recommendations in this article are the following: for dosing of VKAs, we
recommend the initiation of oral anticoagulation therapy, with doses between 5 mg and 10 …

[PDF][PDF] Pharmacology and Management of the Vitamin K Antagonists

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - CHEST, 2008 - Citeseer
Among the key recommendations in this article are the following: for dosing of VKAs, we
recommend the initiation of oral anticoagulation therapy, with doses between 5 mg and 10 …

[PDF][PDF] Pharmacology and Management of the Vitamin K Antagonists

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - CHEST, 2008 - mrotte.com
Among the key recommendations in this article are the following: for dosing of VKAs, we
recommend the initiation of oral anticoagulation therapy, with doses between 5 mg and 10 …

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines .

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - Chest, 2008 - europepmc.org
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …

Pharmacology and management of the vitamin K antagonists

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - Chest, 2008 - hero.epa.gov
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …

[PDF][PDF] Pharmacology and Management of the Vitamin K Antagonists

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - 2008 - ildcare.nl
Among the key recommendations in this article are the following: for dosing of VKAs, we
recommend the initiation of oral anticoagulation therapy, with doses between 5 mg and 10 …

[PDF][PDF] Pharmacology and Management of the Vitamin K Antagonists

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - Chest, 2008 - jvsmedicscorner.com
Among the key recommendations in this article are the following: for dosing of VKAs, we
recommend the initiation of oral anticoagulation therapy, with doses between 5 mg and 10 …

[引用][C] Pharmacology and management of the vitamin K Antagonists: American College of Chest Physicians evidence-based clinical practice guidelines

J ANSELL - Chest, 2008 - cir.nii.ac.jp
Pharmacology and management of the vitamin K Antagonists : American College of Chest
Physicians evidence-based clinical practice guidelines (8th Edition) | CiNii Research CiNii 国立 …

Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - …, 2008 - journal.chestnet.org
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …